Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
Open Access
- 9 October 2012
- Vol. 4 (10) , 1399-1440
Abstract
Dysregulation of glutathione homeostasis and alterations in glutathione-dependent enzyme activities are increasingly implicated in the induction and progression of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s diseases, amyotrophic lateral sclerosis, and Friedreich’s ataxia. In this review background is provided on the steady-state synthesis, regulation, and transport of glutathione, with primary focus on the brain. A brief overview is presented on the distinct but vital roles of glutathione in cellular maintenance and survival, and on the functions of key glutathione-dependent enzymes. Major contributors to initiation and progression of neurodegenerative diseases are considered, including oxidative stress, protein misfolding, and protein aggregation. In each case examples of key regulatory mechanisms are identified that are sensitive to changes in glutathione redox status and/or in the activities of glutathione-dependent enzymes. Mechanisms of dysregulation of glutathione and/or glutathione-dependent enzymes are discussed that are implicated in pathogenesis of each neurodegenerative disease. Limitations in information or interpretation are identified, and possible avenues for further research are described with an aim to elucidating novel targets for therapeutic interventions. The pros and cons of administration of N-acetylcysteine or glutathione as therapeutic agents for neurodegenerative diseases, as well as the potential utility of serum glutathione as a biomarker, are critically evaluated.Keywords
This publication has 206 references indexed in Scilit:
- Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathioneFree Radical Biology and Medicine, 2012
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron DeathNeuron, 2011
- Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1G93A mice modelNeurobiology of Disease, 2011
- Modes of Aβ toxicity in Alzheimer’s diseaseCellular and Molecular Life Sciences, 2011
- Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neuronsActa Neuropathologica, 2010
- The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington diseaseJournal of Bioenergetics and Biomembranes, 2010
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Insights into the effects of α-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture dataFree Radical Biology and Medicine, 2008
- Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stressCurrent Opinion in Pharmacology, 2007
- Mitochondrial glutathione transport: Physiological, pathological and toxicological implicationsChemico-Biological Interactions, 2006